Pachychoroid neovasculopathy: A comparative review on pathology, clinical features, and therapy

被引:6
|
作者
Sagar, Pradeep [1 ]
Sodhi, Preetkanwar Singh [2 ]
Roy, Sangeeta [3 ]
Takkar, Brijesh [4 ,6 ]
Azad, Shorya Vardhan [5 ]
机构
[1] Sankara Eye Hosp, Dept Vitreo Retina, Shivamogga, India
[2] Sodhi Eye Hosp, Dept Vitreo Retina, Patiala, Punjab, India
[3] Susrut Eye Fdn & Res Ctr, Dept Vitreo Retina, Kolkata, West Bengal, India
[4] LV Prasad Eye Inst, Smt Kanuri Santhamma Ctr Vitreoretinal Dis, Banjara Hills, Hyderabad 500034, Telangana, India
[5] All India Inst Med Sci, Dr RP Ctr Ophthalm Sci, New Delhi, India
[6] Publ Hlth & Econ Res Ctr IHOPE, Indian Hlth Outcomes, Hyderabad, Telangana, India
基金
英国惠康基金;
关键词
Pachychoroid; pachychoroid neovasculopathy; choroidal neovascular membrane; OPTICAL COHERENCE TOMOGRAPHY; POLYPOIDAL CHOROIDAL VASCULOPATHY; CENTRAL SEROUS CHORIORETINOPATHY; INDOCYANINE GREEN VIDEOANGIOGRAPHY; VERTEPORFIN PHOTODYNAMIC THERAPY; ENDOTHELIAL GROWTH-FACTOR; DOUBLE-LAYER SIGN; MACULAR DEGENERATION; INTRAVITREAL INJECTION; SWEPT-SOURCE;
D O I
10.1177/11206721211036290
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
There have been major changes in our understanding of choroidal diseases in the last decade owing to multiple retinal and choroidal imaging related advances. A major conceptual pivot is establishment of pachychoroid and its spectrum of clinical disorders: pachychoroid pigment epitheliopathy, central serous chorioretinopathy, pachychoroid neovasculopathy, polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization, peripapillary pachychoroid syndrome, and focal choroidal excavation. However, considerable overlaps in manifestations and therapeutics of these disorders make differentiation amongst them difficult. This review is focused on pathogenesis and clinical aspects of pachychoroid neovasculopathy (PNV). Since PNV was defined as a separate entity around 5 years ago, there have been numerous contrasting observations surrounding it. We review and summarize these studies, and also compare PNV with other disorders of the pachychoroid spectrum in detail. There are important differences between etiologies of neovascular age related macular degeneration and PNV. Yet the current treatment strategies for PNV have been extrapolated from the trials for the former. Future research needs to validate this assumption with long-term results.
引用
收藏
页码:767 / 780
页数:14
相关论文
共 50 条
  • [1] Two-Thirds Dose Photodynamic Therapy for Pachychoroid Neovasculopathy
    Tanaka, Koji
    Mori, Ryusaburo
    Wakatsuki, Yu
    Onoe, Hajime
    Kawamura, Akiyuki
    Nakashizuka, Hiroyuki
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (10)
  • [2] Comparative Analysis of the Clinical Features and Long-Term Outcomes of Pachychoroid Neovasculopathy and Type 1 Neovascular Age-Related Macular Degeneration
    You, Jong In
    Kim, Kiyoung
    JOURNAL OF OPHTHALMOLOGY, 2020, 2020
  • [3] Sarcoid arthritis: a review of clinical features, pathology and therapy
    Torralba, KD
    Quismorio, FP
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2003, 20 (02) : 95 - 103
  • [4] ENLARGEMENT OF CHOROIDAL NEOVASCULARIZATION BEFORE RECURRENCE AFTER PHOTODYNAMIC THERAPY FOR PACHYCHOROID NEOVASCULOPATHY
    Hikichi, Taiichi
    Kubo, Natsuki
    Tabata, Moe
    Kurabe, Haruka
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2024, 44 (09): : 1495 - 1503
  • [5] Comparison of Morphological Features of Type 1 CNV in AMD and Pachychoroid Neovasculopathy: An OCTA Study
    Bicer, Ozlem
    Demirel, Sibel
    Yavuz, Zeynep
    Batioglu, Figen
    Ozmert, Emin
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2020, 51 (11): : 640 - 647
  • [6] Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy
    Miki, Akiko
    Kusuhara, Sentaro
    Otsuji, Tsuyoshi
    Kawashima, Yu
    Miki, Katsuaki
    Imai, Hisanori
    Nakamura, Makoto
    Tsujikawa, Akitaka
    PLOS ONE, 2021, 16 (03):
  • [7] Three-year outcome of photodynamic therapy combined with VEGF inhibitor for pachychoroid neovasculopathy
    Nomura, Yoko
    Aoki, Shuichiro
    Kitamoto, Kohdai
    Ueda, Kohei
    Azuma, Keiko
    Inoue, Tatsuya
    Obata, Ryo
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (10) : 3191 - 3200
  • [8] Predictive factors for outcomes of half-dose photodynamic therapy combined with aflibercept for pachychoroid neovasculopathy
    Takeuchi, Jun
    Ota, Hikaru
    Nakano, Yuyako
    Horiguchi, Etsuyo
    Taki, Yosuke
    Ito, Yasuki
    Terasaki, Hiroko
    Nishiguchi, Koji M.
    Kataoka, Keiko
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 261 (08) : 2235 - 2243
  • [9] Anatomical and functional outcome after anti-VEGF therapy in patients diagnosed with pachychoroid neovasculopathy
    Sitnilska, Vasilena
    Pohl, Maximilian
    Altay, Lebriz
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [10] Treatment outcomes of pachychoroid neovasculopathy with photodynamic therapy and anti-vascular endothelial growth factor
    Roy, Rupak
    Saurabh, Kumar
    Shah, Dhaivat
    Goel, Sugandha
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2019, 67 (10) : 1678 - 1683